WHO ICTRP trial
RANDOMIZED PHASE II TRIAL ON PRIMARY CHEMOTHERAPY WITH HIGH-DOSE METHOTREXATE…
EUCTR2005-001055-38-IT · EU Clinical Trials Register · Authorised
Key facts
| Trial ID | EUCTR2005-001055-38-IT |
|---|---|
| Public title | RANDOMIZED PHASE II TRIAL ON PRIMARY CHEMOTHERAPY WITH HIGH-DOSE METHOTREXATE, ALONE OR ASSOCIATED WITH HIGHDOSE CYTARABINE, FOLLOWED BY RESPONSE- AND AGE-TAILORED RADIOTHERAPY FOR IMMUNOCOMPETENT PATIENTS WITH NEWLY DIAGNOSED PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA |
| Scientific title | RANDOMIZED PHASE II TRIAL ON PRIMARY CHEMOTHERAPY WITH HIGH-DOSE METHOTREXATE, ALONE OR ASSOCIATED WITH HIGHDOSE CYTARABINE, FOLLOWED BY RESPONSE- AND AGE-TAILORED RADIOTHERAPY FOR IMMUNOCOMPETENT PATIENTS WITH NEWLY DIAGNOSED PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA |
| Primary sponsor | INTERNATIONAL EXTRANODAL LYMPHOMA STUDY GROUP IELSG |
| Registry | EU Clinical Trials Register |
| Recruitment status | Authorised |
| Study type | Interventional clinical trial of medicinal product |
| Countries | Italy |
| Conditions | primary chemotherapy of primary central nervous system lymphoma with high dose cytarabine plus methotrexate MedDRA version: 6.1 Level: PT Classification code 10012818 |
| Interventions | Pharmaceutical Form: Powder for infusion* INN or Proposed INN: Methotrexate CAS Number: 59-05-2 Concentration unit: mg milligram(s) Concentration type: equal Concentration number: 500- Pharmaceutical Form: Powder for infusion* INN or… |
| Registration date | Apr 4, 2007 |
| Target size | 80 |
| Secondary IDs | IELSG20 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: